Effect of IL-13 treatment on blood leucocyte levels (±SEM)
| Normal range | Time point | Total 7–15×106/μl | PMN 30–55% | Lymphocytes 35–70% | Monocytes 1–5% |
|---|---|---|---|---|---|
| Animal groups: | |||||
| Controls | Day 0 | 6.96 (0.61) | 46.2 (3.2) | 46.0 (1.9) | 3.0 (0.7) |
| Day 28 | 8.42 (1.25) | 45.4 (9.2) | 45.0 (8.7) | 4.2 (1.0) | |
| IL-13 treated | Day 0 | 8.73 (1.71) | 51.7 (12.0) | 41.7 (11.4) | 1.7 (0.8) |
| Day 28 | 13.1 (2.21) | 66.2 (6.1) | 29.2 (5.8) | 1.7 (0.8) | |
Blood samples were collected on the day of treatment initiation (day 0) and at the end of the treatment period (day 28). Blood leucocytes numbers were determined with an automatic Coulter counter.